Approvals· May 28, 2026 · 7 min read
Baxfendy coverage guide: baxdrostat access for uncontrolled hypertension
By Ran Chen#Hypertension#Cardiovascular#FDA Approval
Topic
Aldosterone Synthase Inhibitor
Aldosterone synthase inhibitors, baxdrostat, lorundrostat, resistant hypertension access, cardiorenal pipeline, and payer positioning for the ASI drug class.